logo
#

Latest news with #stomachcancer

South Korean actress Kang Seo Ha dies at 31, five things you need to know
South Korean actress Kang Seo Ha dies at 31, five things you need to know

Khaleej Times

time15-07-2025

  • Entertainment
  • Khaleej Times

South Korean actress Kang Seo Ha dies at 31, five things you need to know

The sudden death of South Korean actress Kang Seo Ha at 31 has shocked fans across the globe. The popular star passed away on June 13 after a battle with stomach cancer, confirmed Korean entertainment channel Soompi. Media reports have since said that a memorial altar has been set up in Room 8 of the funeral hall at Seoul St. Mary's Hospital. The funeral procession will take place at 7.40am on July 16. She will be buried in Haman, Gyeongnam Province. Among those who paid tribute to the star are Park Joo-hyun, who posted on social media: "I pray for the repose of the deceased. Umji... Don't get sick there and keep a pretty smile.' Here are 5 things you didn't know about the star: 1. She was extremely generous Soon after the news of her death was announced, a presumed family member posted a video on social media highlighting moments from her life. In the post, the person wrote about the pain that Kang Seo Ha dealt with while undergoing therapy for her illness. 'Even though you couldn't eat for months, you insisted on paying for my meals with your own card and never let me skip a meal. My angel, who left us far too soon. Even as you endured everything with painkillers, you said you were grateful that it wasn't worse, and I felt truly ashamed. My dear sister, you went through so much. I hope you are only happy and free from pain where you are now,' added the post. View this post on Instagram A post shared by � (@ 2. Kang Seo Ha was not her real name The star of K-dramas such as First Love Again, Schoolgirl Detectives, Assembly, and Through the Waves was born on June 13, 1994, in Buson. Her real name was Kang Ye-won and she had graduated from the Korea National University of Arts. 3. She worked right up until the end A passionate performer, Kang Seo Ha did not let the anguish of chronic illness keep her away from work. She recently finished working on In the Net, or Mangnaein, reported Korean outlet Sports Khan. This project will be released posthumou sly, and also stars actors Kim Seon-Ho (When Life Gives You Tangerines) and Park Gyu-young (Squid Game season 2-3). 4. Debut role The actor, known for her nuanced performances, did not launch her career with a big screen moment. Rather, she made her debut in a music video for Brave Guys' Growing Distant. 5. She was never the leading lady In spite of her playing only supporting roles throughout her decade-long career, she drew the audience's gaze. See her best work in Seonam Girls' High School Detectives, Assembly, First Love Again, Through the Waves, The Flower in Prison, and Heart Surgeons.

Nurse, 30, had common weight loss jab side effect... in fact it was a sign of deadly cancer
Nurse, 30, had common weight loss jab side effect... in fact it was a sign of deadly cancer

Daily Mail​

time15-07-2025

  • Health
  • Daily Mail​

Nurse, 30, had common weight loss jab side effect... in fact it was a sign of deadly cancer

An NHS nurse diagnosed with an aggressive form of stomach cancer at just 28, has revealed how heartburn—which was exacerbated by taking a weight loss jab—was her only symptom. Chloe, now 30, said she had suffered intermittent heartburn since the middle of 2022, about two years before she was diagnosed with the cancer in March last year. In a series of clips on TikTok Chloe said she initially assumed her heartburn was due to a poor diet, noting episodes seemed to be triggered by greasy food and drinking alcohol. However, she noticed her symptoms got far worse after she was prescribed a weight loss jab in November 2023. 'When I was taking that I noticed that the reflux had got a bit worse and I was getting a bit of pain in my sternum that was going through to my back,' she said. 'I had the first dose and my heartburn was horrific that week. 'It was almost this spasm sensation that I was getting.' She added that the pain was so bad she eventually went to A&E for help, and this was when she first suspected something was more seriously wrong with her stomach than simple heartburn. However, she added that: 'As soon as I stopped taking the injections that all went away.' Heartburn is a common side effect of weight loss jabs affecting one in 10 patients taking Mounjaro as well a tenth of those the active ingredient in Ozempic and Wegovy, semaglutide. It was only in January 2024 when Chole went for an endoscopy—where a flexible camera is inserted down the throat and into the stomach—ton investigate her persistent heartburn that medics found traces of something more serious. Images showed what medics initially thought was the remains of an ulcer—an open sore in the stomach—that had since started to heal. Samples taken at the time also confirmed she had a type of bacteria living in her stomach called Helicobacter pylori (H. pylori) a known cause of stomach ulcers and, as Chole would later learn, cancer of the organ. At a follow-up check a few weeks later medics grew increasingly concerned that this 'ulcer' hadn't fully disappeared despite Chole getting treatment, so samples were taken for testing. Three weeks later, the results revealed the devastating truth, the young woman had stomach cancer, a disease that kills over a fifth of patients within a decade. While 'blindsided' by this diagnosis, Chole detailed how even worse news was yet to come. The tests showed she had a particularly aggressive and rare form of the disease called signet ring cell adenocarcinoma. Medics also told Chloe that her cancer was most likely caused by the H. pylori infection. H. pylori—which infests the lining of the stomach and causes damage to tissue that can lead to cancer—is surprisingly common. An estimated two in five Britons have the bug. The vast majority—some eight or nine out of ten—won't know it as the bacteria normally causes no symptoms or only relatively mild problems like indigestion, bloating or nausea that can be easily dismissed. Studies suggest being infected with the bacteria increases the risk of developing stomach cancer six-fold although getting appropriate treatment like antibiotics dramatically reduces this. Data from the British charity Cancer Research UK (CRUK) suggests 41 per cent of the UK's 6,500 annual stomach cancer cases are caused by H. pylori, about 2,700 cases a year. Thankfully for Chole, further tests and scans indicated the cancer had been caught at a very early stage. However, due to its aggressive nature she had her entire stomach—as well as some connecting tissues—removed in a major surgery that followed months of chemotherapy. She has since undergone further chemotherapy in a bid to eliminate any microscopic remains of the cancer missed in the operation, which finished last November. While she will still need to undergo regular scans to ensure the cancer has not returned, Chloe said she was looking forward to the future, even as she grappled with no longer having a stomach. 'Overall I'm doing really well, getting my strength back. I'm training for a half-marathon in October this year,' she said. 'Obviously I've lost a lot of weight because I don't have a stomach so my eating is very different now, I have a lot of smaller portions.' Speaking now in a series of clips which have been viewed over 150,000 times, Chloe said she wanted to raise awareness about the dangers of unaddressed heartburn. 'If you have that (heartburn) it doesn't always mean you have cancer but it's always worth having it checked,' she said. She added she had no other classic symptoms of disease such as losing weight, fatigue, blood in stools, vomiting, or loss of appetite. 'If anyone has heartburn and it's not getting if you're should push your GP to do more investigations and see why,' she said. 'That's why stomach cancer is so hard to detect because heartburn is so common.' Heartburn is an extremely common ailment, affecting about one in four adults in the UK. Chloe's warning comes as the NHS plans to offer heartburn sufferers a new test in high street pharmacies that can detect a condition that dramatically increases the risk of developing oesophageal cancer. She's also not the only patient to have an interesting interaction between cancer symptoms and weight loss jabs. Last week MailOnline reported on a case of a 47-year-old man who revealed how medics missed the early warning signs he had colon cancer as they assumed his symptoms were from taking Mounjaro. About 18 Britons and 83 Americans are diagnosed with stomach cancer each day. The disease kills just over 4,200 patients in the UK each year, with the death toll rising to nearly 11,000 in the US. Only about one in six patients with stomach cancer (17 per cent) are expected to still be alive 10 years after their diagnosis. About one in 92 men and one in 170 women in the UK are estimated to develop stomach cancer in their lifetime. The main symptoms of stomach cancer include heartburn or acid reflux, having problems swallowing, feeling or being sick, indigestion and burping and feeling full very quickly when eating. These symptoms are common and usually caused by other conditions but patients who have had them for over three weeks should contact their GP for advice. Other symptoms include loss of appetite or losing weight without trying, stomach pain, a lump feeling at the top of the stomach and feeling very tired.

The stomach infection fuelling millions of global cancer cases
The stomach infection fuelling millions of global cancer cases

The Independent

time09-07-2025

  • Health
  • The Independent

The stomach infection fuelling millions of global cancer cases

A common bacterium, Helicobacter pylori (H. pylori), is linked to millions of projected stomach cancer cases globally. Scientists estimate 15.6 million people born between 2008 and 2017 will be diagnosed with stomach cancer in their lifetime, with 76 per cent directly linked to H. pylori infection. The vast majority of these projected cases, 10.6 million, are expected in Asia, followed by the Americas, Africa, and Europe. Experts from the International Agency for Research on Cancer (IARC) are calling for greater investment in prevention, particularly through population-wide 'screen and treat' programmes for H. pylori, which could cut cases by up to 75 per cent. Cancer Research UK notes that stomach cancer rates are falling in the UK, where H. pylori infection is less common, and other lifestyle factors are more significant for cancer prevention.

Almost 12 million stomach cancer cases linked to common infection
Almost 12 million stomach cancer cases linked to common infection

The Independent

time07-07-2025

  • Health
  • The Independent

Almost 12 million stomach cancer cases linked to common infection

Infection with a common bacterium, Helicobacter pylori (H. pylori), is linked to a significant number of global stomach cancer cases. Experts project that 11.9 million of the 15.6 million stomach cancer diagnoses expected in people born between 2008 and 2017 will be directly caused by H. pylori infection. The majority of these projected cases, 10.6 million, are anticipated in Asia, with millions more in the Americas, Africa, and Europe. Scientists from the International Agency for Research on Cancer advocate for widespread "screen and treat" programmes for H. pylori, which could reduce stomach cancer cases by up to 75 per cent. In contrast, Cancer Research UK notes that stomach cancer rates in the UK are falling and H. pylori infection is less common, with other lifestyle factors being more significant for cancer prevention.

This common bacteria could be the culprit behind ‘millions' of stomach cancer cases
This common bacteria could be the culprit behind ‘millions' of stomach cancer cases

Yahoo

time07-07-2025

  • Health
  • Yahoo

This common bacteria could be the culprit behind ‘millions' of stomach cancer cases

A common bacterium is fuelling millions of stomach cancer cases globally, though screening may offer a vital solution, experts say. Scientists from the International Agency for Research on Cancer (IARC), part of the World Health Organisation, project that if current trends continue, around 15.6 million people born between 2008 and 2017 will be diagnosed with stomach (gastric) cancer in their lifetime. Of these cases, a staggering 11.9 million – 76 per cent – are directly linked to infection with Helicobacter pylori (H. pylori). While the vast majority of new cases will be in Asia (particularly India and China), some two million could occur in the Americas, 1.7 million in Africa and 1.2 million in Europe. H. pylori is a bacteria that infects the lining of the stomach and is thought to be spread from person to person and via contaminated food and water. Research is still ongoing into how the infection is spread and how it may cause stomach cancer and another type, non-Hodgkin lymphoma. For many people, H. pylori does not cause issues and will not need the standard treatment of antibiotics, but it can be the cause of ongoing indigestion, bloating or nausea. H. pylori is detected with a blood test, breath test or via a stool sample. The authors of the latest study are now calling for greater investment in the prevention of stomach cancer, particularly through population-wide 'screen and treat' programmes for H. pylori. However, Cancer Research UK said stomach cancer rates in the UK have actually been falling – over the last decade, they have dropped 26 per cent and are projected to fall further by 2040. Health information manager at Cancer Research UK, Dr Rachel Orritt, said: 'H. pylori infection increases the risk of stomach cancer, but it's not a common infection in the UK. 'It's also important to note that stomach cancer cases have been decreasing in the UK for decades, and they're expected to continue to fall. 'Although this is an important issue worldwide, in the UK other preventable factors cause more cancer cases. 'Ways to reduce your cancer risk include stopping smoking, keeping a healthy weight, cutting down on alcohol and eating a healthy, balanced diet.' For the Nature Medicine study, scientists examined the incidence of stomach cancer from 185 countries in 2022 and combined it with projections of future deaths. They looked at the potential impact of screen-and-treat strategies for H. pylori and found the number of stomach cancers could be cut by up to 75 per cent overall. Asia accounts for two thirds of projected future cases, with 10.6 million cases (68 per cent of the total), followed by the Americas (2m or 13 per cent), Africa (1.7 million or 11 per cent), Europe (1.2m or 8 per cent), and Oceania (0.07m or 0.4 per cent). Dr Jin Young Park, leader of the gastric cancer prevention team at IARC and co-author of the study, said: 'It is essential that health authorities make gastric cancer prevention a priority and accelerate efforts to control it by planning pilot and feasibility projects, including H. pylori screen-and-treat programmes.' The main symptoms of stomach cancer include heartburn or acid reflux, having problems swallowing, feeling or being sick, indigestion and burping and feeling full very quickly when eating. These symptoms are common and usually caused by other conditions. Other symptoms include loss of appetite or losing weight without trying, stomach pain, a lump feeling at the top of the stomach and feeling very tired.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store